Former United States President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, according to a statement released by his personal office on Sunday.

The 82-year-old former president underwent medical evaluation last week after experiencing increasing urinary symptoms. Subsequent tests revealed a prostate nodule, and on Friday, he received a diagnosis of prostate cancer with a Gleason score of 9 (Grade Group 5), indicating a highly aggressive form of the disease.

Medical examinations also confirmed that the cancer has metastasized to Biden's bones, complicating his prognosis. However, his medical team noted that the cancer appears to be hormone-sensitive, which they say "allows for effective management" despite its aggressive nature.

"While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management," the statement said.

Biden and his family are currently reviewing treatment options with his medical team, according to the statement from his office.

The diagnosis comes approximately ten months after Biden withdrew from the 2024 presidential race amid growing concerns about his age and health. His decision followed a widely criticized debate performance against Donald Trump in June 2024, during which he appeared to struggle with coherence and physical stamina.

Biden officially ended his re-election campaign on July 21, 2024, and endorsed then-Vice President Kamala Harris as the Democratic nominee. Despite his endorsement, Harris was defeated by Donald Trump, who was inaugurated for his second term as president on January 20, 2025.

Since completing his term in office, Biden has largely stepped away from public life, making only occasional appearances while remaining a symbolic figure within the Democratic Party.

Prostate cancer is one of the most common forms of cancer among men, particularly in older age groups. Treatment options typically include surgery, radiation therapy, hormone therapy, chemotherapy, or a combination of these approaches, depending on the stage and aggressiveness of the disease.